MIRA INFORM REPORT

 

 

Report Date :

27.04.2013

 

IDENTIFICATION DETAILS

 

Name :

BAYER CROPSCIENCE LIMITED (w.e.f 2004)

 

 

Formerly Known As :

BAYER (INDIA) LIMITED

 

 

Registered Office :

Bayer House, Central Avenue, Hiranandani Gardens, Powai, Mumbai – 400 076, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

09.09.1958

 

 

Com. Reg. No.:

11-011173

 

 

Capital Investment / Paid-up Capital :

Rs.394.000  Millions

 

 

CIN No.:

[Company Identification No.]

L24210MH1958PLC011173

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMB00146G

 

 

PAN No.:

[Permanent Account No.]

AAACB9651K

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturing selling and distribution of insecticides, fungicides, weedicides and various other agrochemical products.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Aa (75)

 

RATING

STATUS

PROPOSED CREDIT LINE

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

 

Maximum Credit Limit :

USD 31000000

 

 

Status :

Excellent

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of Bayer AG, Germany. It is a well-established and a reputed company having fine track record. Financial position of the company appears to be sound. Fundamentals are strong and healthy. Directors are reported to be experienced and respectable businessmen. Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered good for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Rating : AA+

Rating Explanation

High degree of safety and very low credit risk.

Date

05.11.2012

 

Rating Agency Name

CRISIL

Rating

Short Term Rating : A1+

Rating Explanation

Very strong degree of safety and lowest credit risk.

Date

05.11.2012

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office :

Bayer House, Central Avenue, Hiranandani Gardens, Powai, Mumbai – 400 076, Maharashtra, India

Tel. No.:

91-22-25711234 / 25711391/ 25711388/ 25711395

Fax No.:

91-22-25700147

E-Mail :

info@bayerindia.com

shirin.balsara@bayercropscience.com

rajiv.wani@bayer.com

Website :

www.bayergroupindia.com

www.bayerindia.com

www.bayercropscience.com

 

 

Factory 1 :

Plot Nos. 6008 - 10 and 6301 - 10A, GIDC Industrial Estate, Ankleshwar – 393002, Gujarat, India

 

 

Factory 2 :

Plot Nos. 66/1 to 75/2, GIDC,  Estate, Himatnagar – 383001, Gujarat, India

 

 

DIRECTORS

 

AS ON 31.03.2012

 

Name :

Dr. Vijay Mallya

Designation :

Chairman and Independent Director

 

 

Name :

Mr. Stephan Gerlich

Designation :

Vice Chairman and Managing Director

 

 

Name :

Mr. Sharad M Kulkarni

Designation :

Independent Director

 

 

Name :

Mr. A K Ravi Nedungadi

Designation :

Independent Director 

 

 

Name :

Mr. Vimal Bhandari

Designation :

Director

 

 

Name :

Mr. Peter Mueller

Designation :

Director

 

 

Name :

Mr. Tobias Marchand

Designation :

Director

 

 

Name :

Mr. Kaikobad Mistry

Designation :

Whole Time Director

 

 

Audit Committee:

Mr. A K Ravi Nedungadi (Member)

 

Mr. Sharad M Kulkarni (Chairman)

 

 

Shareholders' Grievance Committee:

Mr. Sharad M Kulkarni (Chairman)

 

Mr. Stephan Gerlich (Promoter Director Member)

 

 

KEY EXECUTIVES

 

Name :

Mr. Shirin V. Balsara

Designation :

Vice President – Legal and Company Secretary

 

SHAREHOLDING PATTERN

 

AS ON 31.12.2013

 

Category of Shareholders

Total No. of Shares

Total Shareholding as a % of total No. of Shares

(A) Shareholding of Promoter and Promoter Group

 

 

(1) Indian

 

 

Bodies Corporate

6637798

16.81

 

 

(2) Foreign

 

 

Bodies Corporate

21448864

54.30

 

 

Total shareholding of Promoter and Promoter Group (A)

280866962

71.11

(B) Public Shareholding

 

 

(1) Institutions

 

 

Mutual Funds / UTI

2882020

7.30

Financial Institutions / Banks

14319

0.04

Insurance Companies

1709448

4.33

Foreign Institutional Investors

1846473

4.67

Sub Total

6452260

16.34

 

 

 

(2) Non-Institutions

 

 

Bodies Corporate

1445561

3.66

 

 

 

Individuals

 

 

Individual shareholders holding nominal share capital up to Rs.0.100 Million

3065781

7.76

Individual shareholders holding nominal share capital in excess of Rs.0.100 Million

442115

1.12

 

 

 

Any Others (Specify)

 

 

Directors & their Relatives & Friends

53

0

Trusts

6315

0.02

 

 

 

Total (A+B)

4959825

12.56

 

 

 

(C) Share held by custodian and against which depository Receipts have been issued

 

 

          Promoter and promoter group

0

0

          Public

0

0

Sub Total

0

0

Total (A+B+C)

39498747

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing selling and distribution of insecticides, fungicides, weedicides and various other agrochemical products.

 

 

Products :

Item Code No. (ITC Code)

 

Product Description

380810.11

Imidacloprid

380810.99

Triazophos

380850.00

Fipronil

 

 

PRODUCTION STATUS (AS ON 31.03.2011)

 

Particulars

Unit

Installed Capacity

Actual Production

Active Ingredient Production

Tons

5783

2192

Formulations

 

 

 

Powders

Tons

12610

5209

Liquids

KL

3600

2321

Wetable dispersable granules

Tons

720

13370

Tablets

Million Nos

--

--

 

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

  • Bank of America
  • BNP Paribas
  • Central Bank of India
  • Citibank N.A.
  • Credit Agricole Corporate and Investment Bank
  • Deutsche Bank
  • HDFC Bank Limited
  • Societe Generale
  • Standard Chartered Bank
  • State Bank of India
  • Union Bank of India

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Price Waterhouse

Chartered Accountants

 

 

Ultimate Holding Company:

Bayer AG, Germany

 

 

Parties under common control :

-          Bayer (China) Limited, China

-          Bayer (South East Asia) Pte Limited, Singapore

-          Bayer A/S, Denmark

-          Bayer Animal Health GmbH, Germany

-          Bayer Australia Limited, Australia

-          Bayer Bio Science Private Limited, India

-          Bayer Business and Technology Services LLC, U.S.A.

-          Bayer Business Services GmbH, Germany

-          Bayer Business Services Private Limited, India (from December 1, 2010)

-          Bayer Company (Malaysia) Sdn. Bhd., Malaysia

-          Bayer CropScience (China) Company Limited, China

-          Bayer CropScience Private Limited, Pakistan

-          Bayer CropScience AG, Germany

-          Bayer CropScience K.K., Japan

-          Bayer CropScience LP, U.S.A.

-          Bayer CropScience Limited, Korea

-          Bayer CropScience Limited, Bangladesh

-          Bayer CropScience Inc., Philippines

-          Bayer Direct Services GmbH, Germany

-          Bayer HealthCare Limited, Hong Kong

-          Bayer HealthCare LLC, U.S.A.

-          Bayer Korea Limited, Korea

-          Bayer Malibu Polymers Private Limited, India

-          Bayer MaterialScience AG, Germany

-          Bayer MaterialScience Limited, Hong Kong

-          Bayer MaterialScience Private Limited, India

-     Bayer Middle East FZE, United Arab Emirates

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

46300000

Equity Shares

Rs.10/- each

Rs.463.000  Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

39498747

Equity Shares

Rs.10/- each

Rs.395.000 Millions

 

 

 

 

 

Notes to the financial statements for the year ended March 31, 2012

 

Share Capital

As On

31.03.2012

(Rs. In Millions)

1] Authorised

46,300,000 Equity Shares of Rs. 10/- each

 

463.000

2] Issued, Subscribed and Paid-up:

 

39,498,747 Equity Shares of Rs. 10/- each, fully paid-up

 

395.000

 

a) Rights, preferences and restrictions attached to Equity Shares:

 

The Company has one class of Equity Shares having a par value of Rs. 10/- per share. Each Shareholder is eligible for one vote per share held. The dividend proposed by the Board of Directors is subject to the approval of the Shareholders in the ensuing Annual General Meeting. In the event of liquidation, the Equity Shareholders are eligible to receive the remaining assets of the Company after distribution of all preferential amounts, in proportion to their shareholding.

 

b) Shares held by Ultimate Holding Company and its subsidiaries:

 

Number of Shares

 

As On 31.03.2012

Ultimate Holding Company: Bayer AG, Germany

8272560

Ultimate Holding Company: Bayer AG, Germany

11236586

Bayer S.A.S., France

7922666

Bayer MaterialScience Private Limited, India

654850

 

Note: There are no shareholders holding more than 5% of the aggregate Equity Shares of the Company except those marked above.


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

395.000

395.000

394.987

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

7532.000

6335.000

5202.938

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

7927.000

6730.000

5597.925

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

14.906

2] Unsecured Loans

0.000

1085.000

1124.843

TOTAL BORROWING

0.000

1085.000

1139.749

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

7927.000

7815.000

6737.674

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

2558.000

3537.000

2921.096

Capital work-in-progress

8.000

0.000

287.359

 

 

 

 

INVESTMENT

36.000

36.000

628.175

DEFERREX TAX ASSETS

104.000

60.000

66.118

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

4995.000

4374.000

3479.998

 

Sundry Debtors

2562.000

2814.000

1976.014

 

Cash & Bank Balances

4299.000

3630.000

153.514

 

Other Current Assets

1064.000

1137.000

0.000

 

Loans & Advances

2781.000

9.000

1182.851

Total Current Assets

15701.000

11964.000

6792.377

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

2605.000

2950.000

2640.453

 

Other Current Liabilities

7292.000

4376.000

882.400

 

Provisions

583.000

456.000

434.598

Total Current Liabilities

10480.000

7782.000

3957.451

Net Current Assets

5221.000

4182.000

2834.926

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

7927.000

7815.000

6737.674

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

22723.000

21373.000

16247.619

 

 

Other Income

453.000

205.000

1245.969

 

 

TOTAL                                    

23176.000

21578.000

17493.588

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

5013.000

4072.000

3855.839

 

 

Purchases of Stock-in-Trade

10283.000

10038.000

6627.115

 

 

Changes in inventories of semi-finished goods, finished goods and stock-in-trade

(739.000)

(368.000)

122.235

 

 

Employee benefit expenses

1553.000

1566.000

1411.231

 

 

Other expenses

4086.000

3834.000

3033.201

 

 

TOTAL                                    

20196.000

19142.000

15049.621

 

 

 

 

 

Less

PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

2980.000

2436.000

2443.967

 

 

 

 

 

Less

FINANCIAL EXPENSES                        

17.000

83.000

128.316

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

2963.000

2353.0000

2315.651

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                    

340.000

327.000

264.419

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX AND EXCEPTIONAL ITEMS   

2623.000

2026.000

2051.232

 

 

 

 

 

Less

EXCEPTIONAL ITEM

579.000

38.000

86.785

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX

2044.000

1988.000

1964.447

 

 

 

 

 

Less

TAX                                                                 

654.000

672.000

691.912

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX

1390.000

1316.000

1272.535

 

 

 

 

 

 

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

5032.000

4032.03

3070.989

 

 

 

 

 

 

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

166.000

158.000

158.000

 

 

Dividend

27.000

26.000

26.240

 

 

Tax on Dividend

139.000

132.000

127.250

 

BALANCE CARRIED TO THE B/S

6090.000

5032.000

4032.03

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Service Charges Recover From Group of Companies

68.000

607.000

629.455

 

 

Proceeds From Global Disinvestment of Carbaryl

24.000

-

N.A

 

 

Reimbursement OF Expenses

53.000

135.000

N.A

 

 

Export of Goods

3096.000

2363.000

N.A

 

TOTAL EARNINGS

3241.000

2498.000

629.455

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

2642.000

2694.000

3483.283

 

 

Packaging Material

17.000

6.000

N.A

 

 

Stock In Trade

1955.000

1896.000

15.480

 

 

Stores & Spares

10.000

9.000

1.442

 

 

Capital Goods

107.000

103.000

91.646

 

TOTAL IMPORTS

4731.000

4708.000

108.568

 

 

 

 

 

 

Earnings Per Share (Rs.)

35.19

33.30

32.22

 

 

 

QUARTERLY RESULTS

 

 

PARTICULARS

30.06.2012

 

30.09.2012

31.12.2012

 

1st Quarter

2nd Quarter

3rd Quarter

Net Sales

9208.200

8265.600

5875.000

Total Expenditure

7819.100

6798.300

5242.000

PBIDT (Excl OI)

1389.100

1467.300

633.000

Other Income

224.400

138.100

115.000

Operating Profit

1613.500

1605.400

748.000

Interest

3.700

9.500

12.000

Exceptional Items

(217.800)

(61.400)

11179.000

PBDT

1392.000

1534.500

11915.000

Depreciation

86.9000

88.400

95.000

Profit Before Tax

1305.100

1446.100

11820.000

Tax

417.700

467.600

2786.000

Provisions and contingencies

0.000

0.000

0.000

Profit After Tax

887.400

978.500

9034.000

Extraordinary Items

0.000

0.000

0.000

Prior Period Expenses

0.000

0.000

0.000

Other Adjustments

0.000

0.000

0.000

Net Profit

887.400

978.500

9034.000

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

5.99

6.10

7.27

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

8.99

9.30

11.39

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

11.19

12.82

20.22

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.25

0.30

0.35

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.00

0.16

0.20

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.50

0.25

0.17

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

No

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

No

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

UNSECURED LOAN DETAILS

 

Particulars

Rs. In Millions

31.03.2012

Rs. In Millions

31.03.2011

Loans and Advances from Related Parties (Bilag Industries Private Limited)

0.000

1085.000

TOTAL

0.000

1085.000

 

OPERATION

 

The company’s profit after tax increased to Rs.1390.000 Millions during the financial year ended March 31, 2012 as compared to Rs.1316.000 Millions in previous year, an increase of 5.62 %.

 

MANAGEMENT DISCUSSION AND ANALYSIS REPORT

 

OVERVIEW OF AGRICULTURAL SECTOR

 

The story of India remains encouraging. These are challenging times: the economy is going through a phase of slowing growth and high inflation combined with a global prospect that is not entirely supportive of economic enhancement. Despite these factors, the GDP growth for 2011-12 is estimated at 6.5%, which will support further growth in the agriculture sector.

 

The agricultural sector has continued its steady growth, estimated to be around 3%, for ‘agriculture and allied activities’, according to the Central Statistical Organization. The main impetus for growth during 2011-12 emanated from agriculture, which showed an above-trend growth rate, thanks to a normal monsoon. The year also witnessed record production in wheat, coarse cereals, pulses and cotton.

 

With the announcement made by the Planning Commission, growth in the agricultural sector has made up for the shortfall in industrial output.

 

The second advance estimates released by the Ministry of Agriculture, state that India is likely to produce 250.400 Million tonnes of food grain compared to 232.100 Million tonnes last year, which in itself was considered as an all-time record. Wheat production is expected to reach 88.300 Million tonnes, pulses 17.300 Million tonnes, oilseeds 30.500 Million tonnes and rice is estimated at 102.800 Million tonnes. Production of cotton reached a record of 34.100 Million bales (of 170 kg each) this year.

 

Various initiatives launched by the Government of India such as Rashtriya Krishi Vikas Yojana (launched in 2007) to boost agricultural growth rate are showing significant results. In addition, the Government of India’s encouragement towards incentivising states to increase public investment in agriculture, extending the Green Revolution to eastern states such as West Bengal and Assam, the National Horticultural Mission to promote fruits and vegetables and the increased Minimum Support Prices (MSP) for farmers have been contributing to the holistic development in this sector.

 

The above initiatives, coupled with private sector participation, have shown significant improvement. These are expected to boost the growth of Indian agricultural sector in 2012.

 

INDUSTRY DEVELOPMENT

 

The Indian crop protection market has been growing steadily at nearly 14% during the last 4 years. However, in 2011-12, the crop protection season has slowed down to a single digit growth rate, mainly due to the uneven spread of the south west monsoon, relatively less favorable commodity prices and especially critical cropping condition during the recent Rabi season. It is important to emphasise that the overall positive market trends in the agricultural sector are fully in place and the agrochemicals industry is well synchronized to match with them. A number of reasons have been attributed to the long-term positive market trend, such as good commodity prices and Minimum Support Price from the Government of India, that has been helping farmers to choose qualitative inputs as well as increasing awareness amongst farmers about development in cropping patterns.

 

Indian agrochemical companies have been contributing substantially towards generating awareness among farmers about sound crop protection practices. Diversity of crops across newer geographical areas has brought in a gainful period for the agricultural sector and in particular to the crop protection industry.

 

Newer chemistry is entering the markets, as companies focus on innovation. Farmers today are more educated and their acceptance towards newer trends is much higher than ever before. Quality has become a watchword for farmers, as exports of fruits and vegetables are increasingly offering price advantages to them. Their power of choice has also contributed to an ever-expanding range of crop protection products.

 

The option for greater use of herbicides is on account of labour shortage spurred by Mahatma Gandhi National Rural Employment Guarantee Scheme as also greater employment opportunities in the manufacturing and service sectors across the country.

 

There is also a higher acceptance for new products. Farmers are now well aware about the demand for quality of produce in fruit and vegetable segments and are increasingly opting for fungicides, which has remarkably spurred the growth of this segment.

 

The Public Health business segment in India grew during the financial year 2011-12 because of continued incidences of vector borne diseases like malaria and dengue. Bednets have emerged as the most significant new category due to increase in global funding in order to cover the rural population susceptible to malaria. Local Bodies on the other hand have continued practicing ‘Larvicides and Space Spraying’ in order to protect the urban citizens from malaria as well as dengue. Indoor Residual Spraying as a practice was observed mostly in the form of ‘DDT’ in areas like Bihar and Orissa prone to ‘Kala Azar’.

 

Professional Pest Control (PPC) business also continued its positive growth curve in both commercial and residential segments. Synthetic pyrethroids are still used for active treatments of various pests. A latent demand for ‘natural / alternative products’ is met by unbranded products in the unorganised sector. Termite control products business keeps growing with the increase in new constructions. Bedbugs are posing a major threat to households and hospitality industry and are emerging as a key segment apart from roaches and rodents. The segment grew overall by 12% as compared to last year.

 

OPPORTUNITIES AND OUTLOOK

 

The outlook for crop protection companies continues to be positive. Innovation-driven companies will achieve better consolidation in terms of value capture, say experts. Better quality molecules and the range of products well-suited for high-value agriculture will ensure growth. Swelling farm incomes, encouraged by good commodity prices, will further embolden farmers in spending on qualitative and innovative crop protection products.

 

Increasing employment opportunities in rural areas, encouraged by progressive government policies and actions and coupled with high economic growth, are expected to influence labour availability for agricultural business. Usage of selective and non-selective herbicides consequently, will get a major impetus due to this phenomenon.

 

Quality-conscious consumers will impact the market. This will boost fungicides segment and create opportunities for the crop protection products in Horticultural crop cultivation.

 

While the government has taken proactive steps to give remunerative prices to farmers, the full benefit will flow to them with the strengthening of procurement and improved distribution systems.

The Company is well positioned as an innovation leader in the industry. By implementing a comprehensive business strategy, the Company is poised strongly in the market with an extensive pipeline of products that are being developed keeping in sight the evolving market trends. The Company’s focus on innovation will ensure that it benefits from the existing growth trends.

 

With more than 3,500 sales managers and field advisers, as well as a large distribution network, the Company has the deepest reach in the Indian market. This helps in providing necessary insight into farmer needs and the capability to respond accordingly.

 

An increased reach, focus on large and medium sized customers as Key Accounts and a growing PMP segment are some of the main contributors that will help Bayer consolidate its position in 2012 and onwards. This year the outlook seems bright, as the Company is reintroducing some earlier products, as also launching new ones. Bayer is also introducing new tools like the ‘Safety Card’ to help the Company make further inroads in the PMP segment

 

CONTINGENT LIABILITIES

(Rs. In Millions)

Particulars

 

31.03.2012

31.03.2011

Claims against the Company not acknowledged as debts towards:

 

 

Direct Tax matters

461.000

171.000

Indirect Tax matters (Excise duty, Customs duty, Service tax and Sales tax)

7633.000

754.000

Litigation/ claims filed by customer/ vendor/ labour

33.000

33.000

Litigation/ demands raised by other Statutory Authorities

53.000

28.000

TOTAL

8180.000

986.000

 

Note: Future cash flows in respect of above, if any, is determinable only on receipt of judgment/ decisions pending with relevant authorities

 

 

FIXED ASSETS

 

·         Freehold Land

·         Leasehold Land

·         Buildings

·         Plant and Machinery

·         Office Equipment

·         Computers

·         Furniture and Fixtures

·         Vehicles

 

 

STATEMENT OF UNAUDITED RESULT FOR THE QUARTER AND NINE MONTHS ENDED DECEMBER 31, 2012

(Rs. in Millions)

Particulars

 

Quarter Ended On 31.12.2012

Quarter Ended On 30.09.2012

Year

Ended On 31.12.2012

Income from Operations

(UnAudited)

(UnAudited)

(UnAudited)

(a) Net Sales/Income from Operations

5591.000

8001.000

22586.000

     (Net of Excise duty)

 

 

 

(b) Other Operating Income

284.000

265.000

762.000

Total Income from Operations (Net)

5875.000

8266.000

23348.000

Expenses

 

 

 

Cost of material consumed

1240.000

1317.000

4006.000

Purchase of stock in trade

908.000

3351.000

10489.000

Changes in inventories of finished goods, in progress and Stock- in- trade

1487.000

463.000

455.000

Employee benefit expenses

450.000

450.000

1378.000

Depreciation and amortisation expenses

95.000

88.000

270.000

Other Expenses

1157.000

1218.000

3532.000

Total Expenses

5337.000

6887.000

20130.000

Profit from Operations before other income, Finance cost and Exceptional items                

538.000

1379.000

3218.000

Other Income

115.000

138.000

477.000

Profit from ordinary activities before finance costs and Exceptional items (3+4)

653.000

1517.000

3695.000

Finance Costs

12.000

10.000

25.000

Profit from ordinary activities after finance costs but before Exceptional items (5-6)

641.000

1507.000

3670.000

Exceptional items:

 

 

 

Profit on sale of land and building

11082.000

--

11082.000

Demolition and Remediation (Expenditure) (Net of one-time recovery of 143.000 Millions during the quarter ended December 31, 201)

97.000

(61.000)

(182.000)

Exceptional items

11179.000

(61.000)

10900.000

Profit/Loss from ordinary activities before tax (7+8)

11820.000

1446.000

14570.000

Tax Expense

 

 

 

Tax Expense

2786.000

468.000

3671.000

Net Profit from ordinary activities after tax      (9-10)

9034.000

978.000

10899.000

Paid up Equity Share Capital ( Face Value Rs.10 each)

395.000

395.000

395.000

Reserves excluding revaluation reserves as per balance sheet of previous year accounting

 

 

 

Earning Per Share (basic and dillute) (non audited)

228.72

24.77

275.94

PARTICULARS OF SHARE HOLDING Public Shareholding

 

 

 

No of Equity Shares

11412085

11412085

11412085

% of Share holding

28.89%

28.89%

28.89%

 

Promoters and Promoter Group

a) Pledged / Encumbered Shareholding

 

 

 

- Number of Equity shares

Nil

Nil

Nil

- %of shares (of the total shareholding of promoter and promoter group)

N.A

N.A

N.A

- Percentage of shares (of the total share capital of the Company)

N.A

N.A

N.A

b) Non - encumbered

 

 

 

- Number of Equity shares

28086662

28086662

28086662

%of shares (of the total shareholding of promoter and promoter group)

100%

100%

100%

- Percentage of shares (of the total share capital of the

71.11%

71.11%

71.11%

 

PARTICULARS

3 Months ended 31.12.2012

INVESTOR COMPLAINTS

 

Pending at the beginning of the quarter

1

Received during the quarter

Nil

Disposed of during the quarter

1

Remaining unresolved at the end of the quarter

Nil

 

 

Notes:

 

1.       The Company has only one reportable business segment, i.e. "Agri Care". The Company’s business is seasonal in nature and hence quarterly figures are not representative of the full year's performance.

 

2.       Consistent with past practice, sales for the nine month ended December 31, 2012 are net of estimated returns of Rs.667.000 Millions (April – December 2011 Rs. 361.000 Millions) in respect of seasonal sales, which, in managements opinion, may need to be reviewed dependent of future circumstances. Sales returns are accounted are actual at the financial year end.

 

3.       Pursuant to the approval of board vide its resolution dated July 19, 2010 and December 22, 2010, for the sale/transfer/disposal of land and building situated at kolshet road, thane (the said property) the company and agile real Estate Private Limited (Agile) have accepted Rs. 12500.000 Millions as full and final aggregate consideration for the sale and transfer of the said property to agile. The company and Agile have, on November 29, 2012 executed two Agreements and other incidental documents and undertaken all the requisite acts for concluding the transaction. The executed two Agreements and other incidental documents and undertaken all the requisite acts for consideration of 7300.000 Million ) (Net of advance of Rs.5200.000 Millions) as full consideration. The company has no further obligations relating to the transfer of the said property.

 

4.       Profit arising on account of sale of the Property is reflected as an Exceptional Item for the quarter and nine months ended December 31, 2012.

 

5 The Bayer Company worldwide place great importance on protecting, the environment and conserving natural resources. Pursjarrt to the cessation of manufacturing activities a- Thane the Company has Incurred expenses towards Demolition and Remediation activities.

 

PARTICULARS

 

Quarter Ended

Year to Date

Previous Year Ended

 

31.12.2012

30.09.2012

31.12.2011

31.12.2012

31.12.2011

31.03.2012

Earnings per share Before Exceptional Items (net Of Tax) (base & diluted) (net annualised) (in)

11 13

25.82

9.55

63.12

45.02

45.09

 

6 During the quarter, the Company has changed its denomination of reported figures from Lacs to Millions and accordingly, the figures for the previous periods have been reported in Millions.

 

7 The above result have been reviewed and recommended by the Audit committee held on January 31, 2013 and approved by the Board of Directors of the Company at its meeting held on January31, 2013 and the statutory auditors have carried out limited review of the results for the quarter ended December 31, 2012.

8 Previous periods figures have been regrouped wherever necessary

 

 

STATEMENT OF ASSETS AND LIABILITIES AS ON   30.09.2012 (UNAUDITED)

 

(Rs. in Millions)

Particulars

Quarter Ended On 30.09.2012

Equities and Liability

 

[A] SHAREHOLDERS FUNDS

 

1] Share Capital

395.000

2] Reserves & Surplus

9397.800

Sub Total

9792.800

[B] Non Current Liability

 

1] Long Term Borrowings

-

2] Differed Tax Liability

395.400

Sub Total

395..400

[C] Current Liabilities

 

1] Trade Payable

3174.500

2] Other Current Liability

7047.900

3] Short – Term Provision

848.500

Sub Total

11070.900

Total Equity and Liability

21259.100

ASSETS

 

[I] Non Current Assets

 

a) Fixed assets

2398.200

b) Non Current Investment

36.100

c)Differed Tax Assets

158.800

d) Long Term Loan and Advances

744.400

Sub Total Non Current Assets

3337.500

[II] Current Assets

 

a) Inventories

5815.600

b) Trade Receivable

7852.900

c) Cash and Cash Equivalents

1564.500

d) Short Term Loan and Advances

2227.100

e) Other Current Assets

1061.500

Sub Total Current Assets

18521.600

TOTAL – Current Assets

21259.100

 

 

WEBSITE DETAILS

 

NEWS

 

BAYER CROPSCIENCE OPENS NEW MUSTARD BREEDING STATION IN INDIA

February 04, 2013

 

• New Breeding Station to boost the company’s seeds business in India

• Focus on breeding and development of core germplasm for high performing Mustard Hybrids

• Mustard is a strategic crop for Bayer’s global oilseeds business Mumbai, February 04, 2013 – The Seeds Business unit of Bayer CropScience India has inaugurated a new Breeding Station in Palwal, Haryana. Its mission is to develop new varieties of Indian Mustard (Brassica juncea), which is closely related to Canola/Rapeseed (Brassica napus).


Bayer CropScience is the global market leader in Canola Hybrid Seeds, with around 25% global market share. This makes Indian Mustard a strategic crop for Bayer. India has approximately 6.5 million hectares under mustard cultivation. Of late, the commercial mustard seed market in India is growing with improved seed replacement rates and an increasing number of farmers inclining towards high yielding commercial seeds. The new station will focus on breeding and development of core germplasm for high performing Mustard Hybrids for both Indian and global markets.


The breeding station will be spread across ten acres of land and will house labs, an administrative building and plots for breeding development. Eight employees stationed at the site will work on developing key trait and breeding targets in the fields of yield assurance through herbicide tolerance; disease control; yield enhancement; seed shatter resistance and oil quality.

 

The research block will have a state-of-the-art pathological laboratory with growth chambers to screen strains and hybrids for disease tolerance. The oil and meal quality laboratory will facilitate in-house estimation of fatty acid profile of oil, oil content and protein composition of meal to serve specific nutritional benefits or industrial uses. The station will also have seed cleaning and seed preparation laboratories, a cold room for germplasm storage and spare labs for future expansion activities, including doubled haploidy and molecular breeding.


Joerg Rehbein, Head of Bayer CropScience, Indian Subcontinent; Satish Patil, Country Head – Seeds and Traits,

Bayer CropScience India and Rick Turner, Global Market Head Wheat and Oilseeds, Bayer CropScience, inaugurated the Mustard Breeding Station in Palwal on February 1, 2013.


Rape, canola or mustard offer valuable protein as food and feed and are also a source of high-quality vegetable oil for human consumption, for industrial lubricants and for biodiesel. Bayer CropScience’s main biotech research center for oilseeds is located in Ghent (Belgium). Besides India, the company’s key breeding stations are located in Canada, Europe and Australia.

 

About Bayer MaterialScience

 

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. This year the company looks back on 150 years of working to fulfill its mission “Bayer: Science For A Better Life”. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 7.255 billion (2011) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 21,000 and is represented in more than 120 countries.

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.29

UK Pound

1

Rs.83.88

Euro

1

Rs.70.67

 

 

INFORMATION DETAILS

 

Information Gathered by :

KVT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

8

OPERATING SCALE

1~10

8

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

9

--PROFITABILIRY

1~10

9

--LIQUIDITY

1~10

9

--LEVERAGE

1~10

8

--RESERVES

1~10

9

--CREDIT LINES

1~10

8

--MARGINS

-5~5

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

75

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.